- Nachrichtendetail
-
06.03.2024 15:07:00 - dpa-AFX: *J&J SEEKS EMA APPROVAL FOR DARZALEX QUADRUPLET THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Frankfurt | 133,880 | 29.05.24 19:07:45 | +1,140 | +0,86% | 133,560 | 133,860 | 133,200 | 132,740 |
